The contrast effects of 1.0M gadobutrol were compared to that of 0.5M gadoteridol in breast cancer at 3T using hybrid MRI protocol which combined conventional DCE (C-DCE) with ultrafast DCE (UF-DCE). The significant differences were observed only in UF-DCE, maximum enhancement ratio (MER) and maximum slope (MS). The slightly higher peak relative enhancement produced by gadobutrol compared with gadoteridol might help in the detection and evaluation of breast lesions in the earlier phases.
This abstract and the presentation materials are available to members only; a login is required.